MAIA Biotechnology, Inc. (MAIA) Stock Analysis — Probabli.AI
AI-powered analysis for MAIA (MAIA Biotechnology, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $1.27 · Market cap: $2.0B · AI outlook: Bullish
MAIA Biotechnology presents a compelling investment opportunity, driven by strong analyst consensus, recent positive clinical trial results, and strategic collaborations with major pharmaceutical firms. Despite current regulatory challenges and cash flow constraints, the potential for breakthrough in cancer treatment positions MAIA for significant growth. Analyst price targets suggest a massive…
Probabilistic 1-Year Outlook
- Bull 60% · Neutral 25% · Bear 15%
- 1-year price estimates — P10: $1 / P50: $2 / P90: $125
- MAIA Biotechnology has several positive indicators, including consistent analyst support, significant partnerships, and funding that position it for strong potential growth despite regulatory and cash burn concerns. The…
5-Year Outlook
- Bull 70% · Neutral 20% · Bear 10%
- 5-year price estimates — P10: $2 / P50: $10 / P90: $100
SWOT Highlights
- Strength: Strong analyst support and high price targets
- Strength: Successful clinical trial results recently reported
- Risk: Regulatory challenges looming
- Risk: High cash burn rate
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
11 Wall Street analysts rate MAIA a BUY with a mean price target of $125.75.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
MAIA forecast details · MAIA sentiment details · MAIA insider activity
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.